Rabbit Recombinant Monoclonal TAGLN/Transgelin antibody. Carrier free. Suitable for IHC-P, WB and reacts with Human, Rat samples.
pH: 7.2 - 7.4
Constituents: PBS
IHC-P | IP | WB | ICC/IF | |
---|---|---|---|---|
Human | Tested | Not recommended | Tested | Not recommended |
Rat | Tested | Not recommended | Tested | Not recommended |
Species | Dilution info | Notes |
---|---|---|
Species Human | Dilution info - | Notes Perform heat-mediated antigen retrieval with citrate buffer pH 6 before commencing with IHC staining protocol. |
Species Rat | Dilution info - | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Human, Rat | Dilution info - | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Human, Rat | Dilution info - | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Human, Rat | Dilution info - | Notes - |
Actin cross-linking/gelling protein (By similarity). Involved in calcium interactions and contractile properties of the cell that may contribute to replicative senescence.
SM22, WS3-10, TAGLN, Transgelin, 22 kDa actin-binding protein, Protein WS3-10, Smooth muscle protein 22-alpha, SM22-alpha
Rabbit Recombinant Monoclonal TAGLN/Transgelin antibody. Carrier free. Suitable for IHC-P, WB and reacts with Human, Rat samples.
pH: 7.2 - 7.4
Constituents: PBS
ab249579 is the carrier-free version of Anti-TAGLN/Transgelin antibody [EPR11995(B)] ab170902.
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
This product is a recombinant monoclonal antibody, which offers several advantages including:
For more information, read more on recombinant antibodies.
Our carrier-free antibodies are typically supplied in a PBS-only formulation, purified and free of BSA, sodium azide and glycerol. The carrier-free buffer and high concentration allow for increased conjugation efficiency.
This conjugation-ready format is designed for use with fluorochromes, metal isotopes, oligonucleotides, and enzymes, which makes them ideal for antibody labelling, functional and cell-based assays, flow-based assays (e.g. mass cytometry) and Multiplex Imaging applications.
Use our conjugation kits for antibody conjugates that are ready-to-use in as little as 20 minutes with 1 minute hands-on-time and 100% antibody recovery: available for fluorescent dyes, HRP, biotin and gold.
This product is compatible with the Maxpar® Antibody Labeling Kit from Fluidigm, without the need for antibody preparation. Maxpar® is a trademark of Fluidigm Canada Inc.
TAGLN also known as Transgelin or SM22-alpha is a protein with a molecular weight of approximately 22 kDa. Structurally it belongs to the calponin family and contains an ACT domain which is critical for its actin-binding ability. It is expressed abundantly in smooth muscle cells where it stabilizes cytoskeletal dynamics by interacting with actin filaments. TAGLN also shows expression in fibroblasts and myofibroblasts supporting structural integrity and cellular movement.
The regulatory involvement of TAGLN in smooth muscle contraction influences cellular activities essential for vascular function. This protein modulates remodeling and differentiation within smooth muscle cells. It can associate with actin and calponin to form complexes that regulate the stability of cytoskeletal structures ensuring effective cellular responses to mechanical stimuli. By linking signal transduction to cytoskeletal mechanics TAGLN facilitates the maintenance of cell shape and tension.
TAGLN plays a role in the regulation of the RhoA/Rho kinase pathway contributing to actin cytoskeleton organization and smooth muscle contraction. Additionally it is involved in the WNT signaling pathway influencing cell proliferation and differentiation. In these pathways TAGLN works with proteins like RhoA and beta-catenin to transmit signals from the extracellular environment to the nucleus impacting gene expression and cellular responses.
Disruptions in TAGLN expression associate with vascular diseases and certain cancers. Downregulation or altered expression patterns can lead to smooth muscle cell dysfunction contributing to atherosclerosis. Similarly TAGLN interacts with proteins such as fibronectin and MMP2 in cancer where its altered expression could promote metastasis and tumor progression. Understanding these connections highlights TAGLN's potential as a target for therapeutic interventions in these diseases.
We have tested this species and application combination and it works. It is covered by our product promise.
We have not tested this specific species and application combination in-house, but expect it will work. It is covered by our product promise.
This species and application combination has not been tested, but we predict it will work based on strong homology. However, this combination is not covered by our product promise.
We do not recommend this combination. It is not covered by our product promise.
We are dedicated to supporting your work with high quality reagents and we are here for you every step of the way should you need us.
In the unlikely event of one of our products not working as expected, you are covered by our product promise.
Full details and terms and conditions can be found here:
Terms & Conditions.
This data was developed using Anti-TAGLN/Transgelin antibody [EPR11995(B)] ab170902, the same antibody clone in a different buffer formulation.Immunohistochemical analysis of paraffin-embedded Human stomach tissue, labeling TAGLN/Transgelin using Anti-TAGLN/Transgelin antibody [EPR11995(B)] ab170902 at a 1/100 dilution. Perform heat mediated antigen retrieval with citrate buffer pH 6 before commencing with IHC staining protocol.
This data was developed using Anti-TAGLN/Transgelin antibody [EPR11995(B)] ab170902, the same antibody clone in a different buffer formulation.Immunohistochemical analysis of paraffin-embedded Human smooth vessels tissue, labeling TAGLN/Transgelin using Anti-TAGLN/Transgelin antibody [EPR11995(B)] ab170902 at a 1/100 dilution. Perform heat mediated antigen retrieval with citrate buffer pH 6 before commencing with IHC staining protocol.
This data was developed using Anti-TAGLN/Transgelin antibody [EPR11995(B)] ab170902, the same antibody clone in a different buffer formulation.Immunohistochemical analysis of paraffin-embedded Human smooth muscle tissue, labeling TAGLN/Transgelin using Anti-TAGLN/Transgelin antibody [EPR11995(B)] ab170902 at a 1/100 dilution. Perform heat mediated antigen retrieval with citrate buffer pH 6 before commencing with IHC staining protocol.
This data was developed using Anti-TAGLN/Transgelin antibody [EPR11995(B)] ab170902, the same antibody clone in a different buffer formulation.
All lanes: Western blot - Anti-TAGLN/Transgelin antibody [EPR11995(B)] (Anti-TAGLN/Transgelin antibody [EPR11995(B)] ab170902) at 1/1000 dilution
Lane 1: Human bladder lysate at 10 µg
Lane 2: Human stomach lysate at 10 µg
Lane 3: Human uterus lysate at 10 µg
All lanes: Goat anti-rabbit HRP at 1/2000 dilution
Developed using the ECL technique.
Predicted band size: 23 kDa
This data was developed using Anti-TAGLN/Transgelin antibody [EPR11995(B)] ab170902, the same antibody clone in a different buffer formulation.
Immunohistochemical analysis of paraffin-embedded Human skeletal mucle with Anti-TAGLN/Transgelin antibody [EPR11995(B)] ab170902 at 1/1000 dilution, followed by a ready to use LeicaDS9800 (Bond™ Polymer Refine Detection).
Negative control: no staining on human skeletal muscle.
The section was incubated with Anti-TAGLN/Transgelin antibody [EPR11995(B)] ab170902 for 30 mins at room temperature.
The immunostaining was performed on a Leica Biosystems BOND RX instrument.
Counterstained with Hematoxylin.
Heat mediated antigen retrieval was performed with Tris-EDTA buffer (pH 9.0, Epitope Retrieval Solution2) for 20 mins.
This data was developed using Anti-TAGLN/Transgelin antibody [EPR11995(B)] ab170902, the same antibody clone in a different buffer formulation.
Immunohistochemical analysis of paraffin-embedded Rat skeletal mucle with Anti-TAGLN/Transgelin antibody [EPR11995(B)] ab170902 at 1/1000 dilution, followed by a ready to use LeicaDS9800 (Bond™ Polymer Refine Detection).
Negative control: no staining on Rat skeletal muscle.
The section was incubated with Anti-TAGLN/Transgelin antibody [EPR11995(B)] ab170902 for 30 mins at room temperature.
The immunostaining was performed on a Leica Biosystems BOND RX instrument.
Counterstained with Hematoxylin.
Heat mediated antigen retrieval was performed with Tris-EDTA buffer (pH 9.0, Epitope Retrieval Solution2) for 20 mins.
This data was developed using Anti-TAGLN/Transgelin antibody [EPR11995(B)] ab170902, the same antibody clone in a different buffer formulation.
Immunohistochemical analysis of paraffin-embedded Human stomach labelling Human stomach with Anti-TAGLN/Transgelin antibody [EPR11995(B)] ab170902 at 1/1000 dilution, followed by a ready to use LeicaDS9800 (Bond™ Polymer Refine Detection).
Positive staining on smooth muscle in human stomach.
The section was incubated with Anti-TAGLN/Transgelin antibody [EPR11995(B)] ab170902 for 30 mins at room temperature.
The immunostaining was performed on a Leica Biosystems BOND RX instrument.
Counterstained with Hematoxylin.
Secondary antibody only control: Secondary antibody is a ready to use LeicaDS9800 (Bond™ Polymer Refine Detection).
Heat mediated antigen retrieval was performed with Tris-EDTA buffer (pH 9.0, Epitope Retrieval Solution2) for 20 mins.
This data was developed using Anti-TAGLN/Transgelin antibody [EPR11995(B)] ab170902, the same antibody clone in a different buffer formulation.
Immunohistochemical analysis of paraffin-embedded Rat colon labelling TAGLN/Transgelin with Anti-TAGLN/Transgelin antibody [EPR11995(B)] ab170902 at 1/1000 dilution, followed by a ready to use LeicaDS9800 (Bond™ Polymer Refine Detection).
Positive staining on smooth muscle in Rat colon.
The section was incubated with Anti-TAGLN/Transgelin antibody [EPR11995(B)] ab170902 for 30 mins at room temperature.
The immunostaining was performed on a Leica Biosystems BOND RX instrument.
Counterstained with Hematoxylin.
Secondary antibody only control: Secondary antibody is a ready to use LeicaDS9800 (Bond™ Polymer Refine Detection).
Heat mediated antigen retrieval was performed with Tris-EDTA buffer (pH 9.0, Epitope Retrieval Solution2) for 20 mins.
This data was developed using Anti-TAGLN/Transgelin antibody [EPR11995(B)] ab170902, the same antibody clone in a different buffer formulation.
Blocking and dilution buffer: 5% NFDM/TBST
Negative control: skeletal muscle.
In Western blot, anti-GAPDH antibody (Anti-GAPDH antibody [EPR16891] - Loading Control ab181602) loading control staining at 1/200000 dilution.
All lanes: Western blot - Anti-TAGLN/Transgelin antibody [EPR11995(B)] (Anti-TAGLN/Transgelin antibody [EPR11995(B)] ab170902) at 1/1000 dilution
Lane 1: Human colon tissue lysate at 20 µg
Lane 2: Human skeletal muscle tissue lysate at 20 µg
Lane 3: Rat colon tissue lysate at 20 µg
Lane 4: Rat skeletal muscle tissue lysate at 20 µg
All lanes: Western blot - Goat Anti-Rabbit IgG H&L (HRP) (Goat Anti-Rabbit IgG H&L (HRP) ab97051)
Predicted band size: 23 kDa
Observed band size: 22 kDa
Exposure time: 6s
This data was developed using Anti-TAGLN/Transgelin antibody [EPR11995(B)] ab170902, the same antibody clone in a different buffer formulation.
Immunohistochemical analysis of paraffin-embedded Human esophagus labelling TAGLN/Transgelin with Anti-TAGLN/Transgelin antibody [EPR11995(B)] ab170902 at 1/1000 dilution, followed by a ready to use LeicaDS9800 (Bond™ Polymer Refine Detection).
Positive staining on smooth muscle in human esophagus.
The section was incubated with Anti-TAGLN/Transgelin antibody [EPR11995(B)] ab170902 for 30 mins at room temperature.
The immunostaining was performed on a Leica Biosystems BOND RX instrument.
Counterstained with Hematoxylin.
Secondary antibody only control: Secondary antibody is a ready to use LeicaDS9800 (Bond™ Polymer Refine Detection).
Heat mediated antigen retrieval was performed with Tris-EDTA buffer (pH 9.0, Epitope Retrieval Solution2) for 20 mins.
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com